- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.82 Å
- Oligo State
- hetero-2-2-2-2-mer
- Ligands
- 4 x FE: FE (III) ION(Non-covalent)
- 50 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 2 residues within 4Å:- Chain A: W.330
- Chain D: F.23
Ligand excluded by PLIPEDO.4: 2 residues within 4Å:- Chain A: Q.395, A.399
Ligand excluded by PLIPEDO.5: 9 residues within 4Å:- Chain A: R.87, E.90, T.91, Y.277, L.278, G.282, A.348, L.350
- Ligands: EDO.9
Ligand excluded by PLIPEDO.6: 1 residues within 4Å:- Chain A: D.510
Ligand excluded by PLIPEDO.8: 8 residues within 4Å:- Chain A: R.175, G.180, N.192, N.262, A.263, T.266
- Chain B: Q.74
- Ligands: EDO.11
Ligand excluded by PLIPEDO.9: 7 residues within 4Å:- Chain A: Y.277, A.339, M.342, W.343, L.350
- Ligands: EDO.5, EDO.15
Ligand excluded by PLIPEDO.10: 2 residues within 4Å:- Chain A: R.322, D.323
Ligand excluded by PLIPEDO.11: 7 residues within 4Å:- Chain A: N.262, Q.445, E.449, R.452, Y.453
- Chain C: Y.147
- Ligands: EDO.8
Ligand excluded by PLIPEDO.12: 3 residues within 4Å:- Chain A: D.440, W.441, R.444
Ligand excluded by PLIPEDO.13: 5 residues within 4Å:- Chain A: K.284, F.285, K.286, E.356, D.357
Ligand excluded by PLIPEDO.14: 4 residues within 4Å:- Chain A: G.311, G.314, V.315, E.316
Ligand excluded by PLIPEDO.15: 6 residues within 4Å:- Chain A: V.94, L.169, G.346, F.347, A.348
- Ligands: EDO.9
Ligand excluded by PLIPEDO.16: 6 residues within 4Å:- Chain A: E.429, F.430, N.431, G.432
- Chain C: G.160, K.162
Ligand excluded by PLIPEDO.17: 5 residues within 4Å:- Chain A: R.66
- Chain E: E.65, F.68, L.72
- Ligands: EDO.45
Ligand excluded by PLIPEDO.18: 1 residues within 4Å:- Chain B: S.307
Ligand excluded by PLIPEDO.19: 7 residues within 4Å:- Chain A: F.68, L.72, F.142
- Chain B: E.48, W.105, H.107
- Chain H: K.95
Ligand excluded by PLIPEDO.20: 5 residues within 4Å:- Chain B: Q.289, T.290
- Chain E: P.9
- Chain F: A.125, S.129
Ligand excluded by PLIPEDO.21: 3 residues within 4Å:- Chain B: P.41, R.42, Y.301
Ligand excluded by PLIPEDO.22: 4 residues within 4Å:- Chain B: Y.139, A.340, V.342, E.343
Ligand excluded by PLIPEDO.23: 4 residues within 4Å:- Chain B: E.243, W.320
- Chain C: I.78, N.126
Ligand excluded by PLIPEDO.24: 2 residues within 4Å:- Chain B: R.118, R.122
Ligand excluded by PLIPEDO.25: 7 residues within 4Å:- Chain C: R.3, I.11, D.48, I.49, D.50, V.51, D.52
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain C: D.26, L.72, T.82, T.83
Ligand excluded by PLIPEDO.27: 4 residues within 4Å:- Chain C: K.30, Q.33, D.34, L.37
Ligand excluded by PLIPEDO.28: 6 residues within 4Å:- Chain A: R.66
- Chain D: E.45, F.97, D.101, I.104, N.105
Ligand excluded by PLIPEDO.29: 6 residues within 4Å:- Chain B: R.9
- Chain D: K.42, A.71
- Chain E: R.77, L.78, G.79
Ligand excluded by PLIPEDO.30: 3 residues within 4Å:- Chain D: S.1, A.2, H.3
Ligand excluded by PLIPEDO.33: 4 residues within 4Å:- Chain E: R.162, R.478, S.479, G.481
Ligand excluded by PLIPEDO.34: 6 residues within 4Å:- Chain B: D.364
- Chain E: L.3, K.4, V.5, R.7
- Chain F: R.134
Ligand excluded by PLIPEDO.35: 3 residues within 4Å:- Chain E: L.398, D.403, P.509
Ligand excluded by PLIPEDO.37: 6 residues within 4Å:- Chain E: Y.277, G.346, A.348, L.350
- Ligands: EDO.39, EDO.40
Ligand excluded by PLIPEDO.38: 4 residues within 4Å:- Chain E: K.284, F.285, K.286, D.357
Ligand excluded by PLIPEDO.39: 8 residues within 4Å:- Chain E: P.168, A.339, M.342, W.343, L.345, G.346
- Ligands: EDO.37, EDO.40
Ligand excluded by PLIPEDO.40: 7 residues within 4Å:- Chain E: V.94, L.169, G.346, F.347, A.348
- Ligands: EDO.37, EDO.39
Ligand excluded by PLIPEDO.41: 5 residues within 4Å:- Chain E: E.429, F.430, N.431, G.432
- Chain G: G.160
Ligand excluded by PLIPEDO.42: 4 residues within 4Å:- Chain E: Y.329, W.330
- Chain H: A.19, F.23
Ligand excluded by PLIPEDO.43: 6 residues within 4Å:- Chain B: F.123, Y.127, T.275
- Chain F: Q.266, P.278, A.282
Ligand excluded by PLIPEDO.44: 6 residues within 4Å:- Chain A: P.9
- Chain B: A.125, A.126
- Chain F: T.286, Q.289, T.290
Ligand excluded by PLIPEDO.45: 6 residues within 4Å:- Chain D: K.95
- Chain E: F.68, F.142
- Chain F: E.48, H.107
- Ligands: EDO.17
Ligand excluded by PLIPEDO.46: 5 residues within 4Å:- Chain F: Y.139, A.340, K.341, V.342, E.343
Ligand excluded by PLIPEDO.47: 4 residues within 4Å:- Chain F: A.229, T.230, E.233, S.327
Ligand excluded by PLIPEDO.48: 6 residues within 4Å:- Chain F: V.238, E.243, W.320, H.323, Y.324
- Chain G: I.78
Ligand excluded by PLIPEDO.49: 3 residues within 4Å:- Chain F: G.206, F.207, D.208
Ligand excluded by PLIPEDO.50: 2 residues within 4Å:- Chain F: S.307, E.308
Ligand excluded by PLIPEDO.51: 5 residues within 4Å:- Chain B: P.14, A.18
- Chain F: P.14, E.15, A.18
Ligand excluded by PLIPEDO.52: 7 residues within 4Å:- Chain G: R.3, I.11, D.48, I.49, D.50, V.51, D.52
Ligand excluded by PLIPEDO.53: 5 residues within 4Å:- Chain G: V.25, D.26, L.72, T.82, G.84
Ligand excluded by PLIPEDO.54: 4 residues within 4Å:- Chain G: K.63, V.66, L.67, E.70
Ligand excluded by PLIPEDO.55: 3 residues within 4Å:- Chain G: K.30, Q.33, D.34
Ligand excluded by PLIPEDO.56: 5 residues within 4Å:- Chain A: R.77, G.79
- Chain F: R.9
- Chain H: K.42, A.71
Ligand excluded by PLIP- 2 x BEZ: BENZOIC ACID(Non-covalent)
BEZ.7: 13 residues within 4Å:- Chain A: L.99, E.103, A.106, E.133, F.177, F.181, L.193, G.197, E.198, T.202, E.232
- Ligands: FE.1, FE.2
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.99, A:F.177, A:F.177, A:F.181, A:L.193, A:E.198, A:T.202
BEZ.36: 14 residues within 4Å:- Chain E: L.99, E.103, A.106, E.133, F.177, F.181, L.193, G.197, E.198, T.202, L.205, E.232
- Ligands: FE.31, FE.32
8 PLIP interactions:8 interactions with chain E- Hydrophobic interactions: E:L.99, E:F.177, E:F.177, E:F.181, E:L.193, E:E.198, E:T.202, E:L.205
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jones, J.C. et al., X-ray Crystal Structures of Methane Monooxygenase Hydroxylase Complexes with Variants of Its Regulatory Component: Correlations with Altered Reaction Cycle Dynamics. Biochemistry (2022)
- Release Date
- 2021-12-29
- Peptides
- Methane monooxygenase component A alpha chain: AE
Methane monooxygenase beta chain: BF
Methane monooxygenase gamma chain: CG
Methane monooxygenase regulatory protein B: DH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
EB
BF
FC
CG
GD
DH
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.82 Å
- Oligo State
- hetero-2-2-2-2-mer
- Ligands
- 4 x FE: FE (III) ION(Non-covalent)
- 50 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x BEZ: BENZOIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jones, J.C. et al., X-ray Crystal Structures of Methane Monooxygenase Hydroxylase Complexes with Variants of Its Regulatory Component: Correlations with Altered Reaction Cycle Dynamics. Biochemistry (2022)
- Release Date
- 2021-12-29
- Peptides
- Methane monooxygenase component A alpha chain: AE
Methane monooxygenase beta chain: BF
Methane monooxygenase gamma chain: CG
Methane monooxygenase regulatory protein B: DH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
EB
BF
FC
CG
GD
DH
H